fluorobenzenes has been researched along with Sepsis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drazen, JM; Gelijns, AC | 1 |
| Albertson, TE; Bernard, GR; Brower, RG; deBoisblanc, BP; Douglas, IS; Hite, RD; Hough, CL; Liu, KD; Matthay, MA; Rock, P; Shanholtz, C; Steingrub, J; Thompson, BT; Truwit, JD | 1 |
| Dong, N; Liu, KD; Truwit, JD | 1 |
| Leaf, DE; Waikar, SS | 1 |
1 trial(s) available for fluorobenzenes and Sepsis
| Article | Year |
|---|---|
Rosuvastatin for sepsis-associated acute respiratory distress syndrome.
Topics: Adult; Aged; Creatine Kinase; Double-Blind Method; Female; Fluorobenzenes; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Failure; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Respiratory Distress Syndrome; Rosuvastatin Calcium; Sepsis; Sulfonamides; Survival Analysis; Treatment Failure | 2014 |
3 other study(ies) available for fluorobenzenes and Sepsis
| Article | Year |
|---|---|
Statin strikeout.
Topics: Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Respiratory Distress Syndrome; Rosuvastatin Calcium; Sepsis; Simvastatin; Sulfonamides | 2014 |
Rosuvastatin for sepsis-associated ARDS.
Topics: Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Respiratory Distress Syndrome; Sepsis; Sulfonamides | 2014 |
Rosuvastatin for sepsis-associated ARDS.
Topics: Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Respiratory Distress Syndrome; Sepsis; Sulfonamides | 2014 |